Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for HPGC Renmintongtai Pharmaceutical's Days Inventory or its related term are showing as below:
SHSE:600829'
s Days Inventory Range Over the Past 10 Years
Min: 37.31 Med: 45.13 Max: 58.39
Current: 43.47
During the past 13 years, HPGC Renmintongtai Pharmaceutical's highest Days Inventory was 58.39. The lowest was 37.31. And the median was 45.13.
SHSE:600829's Days Inventory is ranked better than 95.66% of 921
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs SHSE:600829: 43.47
Inventory Turnover measures how fast the company turns over its inventory within a year.
HPGC Renmintongtai Pharmaceutical's Inventory Turnover for the
three
months ended in Mar. 2026 was 2.07.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
HPGC Renmintongtai Pharmaceutical's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.44.
HPGC Renmintongtai Pharmaceutical (SHSE:600829) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
HPGC Renmintongtai Pharmaceutical's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
HPGC Renmintongtai Pharmaceutical's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
HPGC Renmintongtai Pharmaceutical Days Inventory Related Terms
HPGC Renmintongtai Pharmaceutical Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HPGC Renmintongtai Pharmaceutical Days Inventory Chart
SHSE:600829 vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, HPGC Renmintongtai Pharmaceutical's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HPGC Renmintongtai Pharmaceutical Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, HPGC Renmintongtai Pharmaceutical's Days Inventory distribution charts can be found below:
* The bar in red indicates where HPGC Renmintongtai Pharmaceutical's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HPGC Renmintongtai Pharmaceutical (SHSE:600829) has a Days Inventory of 44.17 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on HPGC Renmintongtai Pharmaceutical and its competitors. This is near median its historical median of 45.13. Over the past decade, HPGC Renmintongtai Pharmaceutical's Days Inventory has ranged from 37.31 to 58.39. According to the industry distribution chart, HPGC Renmintongtai Pharmaceutical ranks #40 out of 921 companies in the Drug Manufacturers industry, placing it in the top 4.3%.
Is HPGC Renmintongtai Pharmaceutical's Days Inventory too high?
HPGC Renmintongtai Pharmaceutical's current Days Inventory of 44.17 is near median its 10-year median of 45.13. Over the past 10 years, this metric has ranged from a low of 37.31 to a high of 58.39. The Drug Manufacturers industry median Days Inventory is 164.48. HPGC Renmintongtai Pharmaceutical's value of 44.17 is 73.1% below this industry median. Based on the distribution chart, HPGC Renmintongtai Pharmaceutical ranks #40 out of 921 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, HPGC Renmintongtai Pharmaceutical has a GF Score™ of 60/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HPGC Renmintongtai Pharmaceutical's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, HPGC Renmintongtai Pharmaceutical ranks #40 out of 921 companies for Days Inventory. This places HPGC Renmintongtai Pharmaceutical in the top 4% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.48. HPGC Renmintongtai Pharmaceutical's value of 44.17 is 73.1% below this benchmark. Historically, HPGC Renmintongtai Pharmaceutical's own Days Inventory has ranged from 37.31 to 58.39 over the past decade. While the company's 10-year median is 45.13 vs. the industry median of 164.48, HPGC Renmintongtai Pharmaceutical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HPGC Renmintongtai Pharmaceutical's current Days Inventory of 44.17 is 73.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on HPGC Renmintongtai Pharmaceutical and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HPGC Renmintongtai Pharmaceutical's current Days Inventory is 44.17, which is near median its own 10-year median of 45.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HPGC Renmintongtai Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, HPGC Renmintongtai Pharmaceutical (SHSE:600829) is currently considered Fairly Valued. The stock's GF Value™ is ¥7.84, compared to a current price of ¥8.52 — trading 8.7% above its estimated fair value. The current Days Inventory is 44.17, which is near median its 10-year median of 45.13 and 73.1% below the Drug Manufacturers industry median of 164.48. HPGC Renmintongtai Pharmaceutical's overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For HPGC Renmintongtai Pharmaceutical (SHSE:600829), the current Days Inventory is 44.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HPGC Renmintongtai Pharmaceutical (SHSE:600829) Overvalued in 2026?
Based on GuruFocus' analysis, HPGC Renmintongtai Pharmaceutical stock appears to be overvalued.
The current stock price of ¥8.52 is trading 8.7% above its estimated GF Value™ of ¥7.84.
GuruFocus considers HPGC Renmintongtai Pharmaceutical to be Fairly Valued.
Key valuation signals for SHSE:600829:
Days Inventory: 44.17 (near median its 10-year median of 45.13)
GF Value™: ¥7.84 vs. price of ¥8.52 (8.7% above fair value)
Industry Position: 73.1% below the Drug Manufacturers median (#40 of 921)
No single metric tells the full story. See the SHSE:600829 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HPGC Renmintongtai Pharmaceutical Business Description
HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.
60GF Score
Get the complete analysis for SHSE:600829
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600829 has been successfully added to your 
